Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT02692456
Eligibility Criteria:
Inclusion Criteria:
* Patients with gastric carcinoma
* Patients with hepato-biliary-pancreatic cancer
* Patients with colonic malignancy
* Patients with peritoneal metastasis
* Patients with extensive hepatic metastasis
* Patients having intractable pain to opioids and other analgesics.
* Patients experienced adverse effects to opioids or other analgesics.
* Patients experienced improved intractable pain after diagnostic celiac plexus block
Exclusion Criteria:
* Patient's refusal
* Patients with bleeding tendency
* Patients with coagulopathy
* Patients who were benefited from oral analgesics with no serious side effects
* Patients with significant cardiac diseases
* Patients with organ failure
* Patients with distant vertebral metastasis
* Evidence of local infection at the puncture site
* Patients who did not experience improved pain after receiving a diagnostic celiac plexus block
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02692456
Study Brief:
Protocol Section:
NCT02692456